GLAND PHARMA
Back to Income Statement
|
GLAND PHARMA Last 5 Year Total Expenditure History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹4,348 Cr | ₹4,332 Cr | ₹2,600 Cr | ₹2,891 Cr | ₹2,161 Cr |
What is the latest Total Expenditure of GLAND PHARMA ?
| Year | Total Expenditure |
|---|---|
| Mar2026 | ₹4,348 Cr |
| Mar2025 | ₹4,332 Cr |
| Mar2024 | ₹2,600 Cr |
| Mar2023 | ₹2,891 Cr |
| Mar2022 | ₹2,161 Cr |
How is Total Expenditure of GLAND PHARMA Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,348 Cr | 0.37 | |
| Mar2025 | ₹4,332 Cr | 66.61 | |
| Mar2024 | ₹2,600 Cr | -10.06 | |
| Mar2023 | ₹2,891 Cr | 33.78 | |
| Mar2022 | ₹2,161 Cr | - | |
Compare Total Expenditure of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹48,537.2 Cr | 2.1% | 4.2% | 47% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,196.0 Cr | 1.8% | -1.7% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹250,390.0 Cr | 2.6% | 9.8% | 54.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,967.0 Cr | 2.4% | -0.5% | 36% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | 1.8% | -3.7% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,329.0 Cr | 4.5% | 1.8% | -10% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 2.1% |
4.2% |
47% |
| SENSEX | 0.1% |
-2.7% |
-8.6% |
You may also like the below Video Courses